Eli Lilly Announces A Global Settlement For All TRT Lawsuits
Eli Lilly Announces A Global Settlement For All TRT Lawsuits
Introduction
Eli Lilly and Company, the maker of Axiron used in the treatment of low testosterone levels is one of the defendants in the over 6,000 centralized testosterone replacement therapy (TRT) lawsuits belonging to MDL No. 2545 in the U.S. District Court for the Northern District of Illinois under U.S. District Judge Matthew Kennelly. The company announced a settlement of all the Axiron cases filed against it in the MDL, a month before the start of its first bellwether trial, resulting in the cancellation of two upcoming trial dates in January and March by Judge Kennelly.
Comments
Latest News
Lawyers to Meet Nov. 5 for Talcum Powder Trial Prep
Categories: Talcum
As the first federal talcum powder bellwether trial approaches, both plaintiffs and defendants have finalized their legal teams and are preparing for a key pretrial conference scheduled for early November.
The upcoming proceedings mark a…
2025 Update: What to Know About PPI Lawsuit Settlements & Payout Dates
Categories: Settlements
Last updated on Oct 27, 2025.
The mass tort litigation involving proton pump inhibitor (PPI) drugs — such as Nexium, Prilosec, Prevacid and Protonix — is entering a pivotal phase in …
New Front Emerges in Fight Against Synthetic Opioids
Categories: Opioids
The U.S. opioid crisis has already claimed hundreds of thousands of lives, with fentanyl standing out as one of the deadliest substances. Now the leading cause of death among Americans aged 18 to 44, fentanyl has become synonymous with overdose…